Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib

2020 ◽  
Vol 472 ◽  
pp. 81-96 ◽  
Author(s):  
Chengzhong Lin ◽  
Zhenhu Ren ◽  
Xi Yang ◽  
Rong Yang ◽  
Yiming Chen ◽  
...  
2018 ◽  
Vol 19 (6) ◽  
pp. 1771 ◽  
Author(s):  
József Dudás ◽  
Wolfgang Dietl ◽  
Angela Romani ◽  
Susanne Reinold ◽  
Rudolf Glueckert ◽  
...  

2021 ◽  
pp. 028418512198897
Author(s):  
Alexey Surov ◽  
Maciej Pech ◽  
Alexander Eckert ◽  
Christoph Arens ◽  
Oliver Grosser ◽  
...  

Background Head and neck squamous cell carcinoma (HNSCC) is a common cancer. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) is a widely used imaging modality in HNSCC. Purpose To provide evident data about associations between 18F-FDG PET and histopathology in HNSCC. Material and Methods The MEDLINE database was screened for associations between maximum standard uptake values (SUVmax) derived from 18F-FDG PET and histopathological features in HNSCC up to May 2020. Only papers containing correlation coefficients between SUVmax and histopathology were acquired. Overall, 23 publications were collected. Results The following correlations were calculated: KI 67: 12 studies (345 patients), pooled correlation coefficient (PCC): 0.23 (95% confidence interval [CI] 0.06–0.40); hypoxia-inducible factor-1α: eight studies (240 patients), PCC: 0.24 (95% CI 0.06–0.42); microvessel density: three studies (64 patients), PCC: 0.33 (95% CI 0.02–0.65); vascular endothelial growth factor: two studies (59 cases), PCC: 0.27 (95% CI 0.02–0.51); tumor suppressor protein p53: four studies (159 patients), PCC: 0.05 (95% CI –0.41 to 0.51); epidermal growth factor receptor: two studies (124 patients), PCC: 0.21 (95% CI 0.05–0.37); tumor cell count: three studies (67 patients), PCC: 0.18 (95% CI –0.06 to 0.42); tumor cell apoptosis: two studies (40 patients), PCC: 0.07 (95% CI = –0.85 to 0.99); B-cell lymphoma-2 protein: two studies (118 patients); PCC: 0.04 (95% CI –0.65 to 0.74); glucose-transporter 1: 10 studies (317 patients), PCC: 0.20 (95% CI 0.10–0.30). Conclusion SUVmax derived from 18F-FDG PET cannot reflect relevant histopathological features in HNSCC.


2007 ◽  
Vol 248 (2) ◽  
pp. 269-279 ◽  
Author(s):  
Mark G. Slomiany ◽  
Leigh Ann Black ◽  
Megan M. Kibbey ◽  
Melissa A. Tingler ◽  
Terry A. Day ◽  
...  

2020 ◽  
Vol 2 (7) ◽  
pp. 398-408
Author(s):  
Sam Faulkner ◽  
Nathan Griffin ◽  
Christopher W. Rowe ◽  
Phillip Jobling ◽  
Janine M. Lombard ◽  
...  

Head & Neck ◽  
2014 ◽  
Vol 37 (10) ◽  
pp. 1410-1416 ◽  
Author(s):  
Elen Alves de Sousa ◽  
Silvia Vanessa Lourenço ◽  
Flávia Paiva Prudente de Moraes ◽  
José Guilherme Vartanian ◽  
João Gonçalves-Filho ◽  
...  

2019 ◽  
Vol 130 (6) ◽  
pp. 1470-1478 ◽  
Author(s):  
Christine E. Lehman ◽  
Ashraf A. Khalil ◽  
Mark J. Axelrod ◽  
Michael I. Dougherty ◽  
Stephen S. Schoeff ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document